Healthcare
Technology
Health

Glaukos

477

$30.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.95 (+3.25%) As of 3:04 PM EDT today
+$0.95 (+3.25%) Today

Why Robinhood?

You can buy or sell Glaukos and other stocks, options, ETFs, and crypto commission-free!

About GKOS

Glaukos Corporation, also called Glaukos, is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. Read More The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in San Clemente, CA.

CEO
Thomas William Burns
Employees
600
Headquarters
San Clemente, California
Founded
1998
Market Cap
1.31B
Price-Earnings Ratio
77.91
Dividend Yield
—
Average Volume
965.68K
High Today
$31.39
Low Today
$29.71
Open Price
$31.20
Volume
549.67K
52 Week High
$84.65
52 Week Low
$23.31

Collections

Healthcare
Technology
Health
Medical
Pharmaceutical
2015 IPO
US
North America

GKOS Earnings

-$0.19
-$0.11
-$0.04
$0.04
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, After Hours

People Also Bought

LexinFintech

1,773

$8.54

+0.47%

LexinFintech

1,773

$8.54

+0.47%

Momo

9,333

$21.45

+4.61%

NVIDIA

90,190

$263.84

+8.17%

Marvell

15,512

$23.35

+4.08%

You May Also Like

NI
AAMC
DTH
PRNB
QDIV
JBT
IETC
FULT
TSG
GJT
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy GKOS

Market Price$30.16
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Glaukos stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up